<DOC>
	<DOCNO>NCT00976534</DOCNO>
	<brief_summary>The primary aim study investigate AZD1386 efficacious analgesic patient peripheral neuropathic pain . This do comparing effect AZD1386 placebo ( `` inactive substance '' ) pain .</brief_summary>
	<brief_title>Study Evaluate Efficacy , Safety , Tolerability Pharmacokinetics AZD1386 Patients With Peripheral Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<criteria>Patients painful symptom due neuropathic pain Provision sign informed consent Non pregnant females Other pain condition may confound assessment neuropathic pain , judge investigator History , and/or presence somatic disease , may interfere objective study judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Analgesic effect</keyword>
	<keyword>Peripheral Neuropathic pain</keyword>
	<keyword>Posttraumatic Neuralgia ( PTN )</keyword>
	<keyword>Postherpetic Neuralgia ( PHN )</keyword>
</DOC>